DGAP-PVR: RHÃ?N-KLINIKUM AG: Release according to Article

RHÃ?N-KLINIKUM AG 04.11.2013 16:30 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG B. Braun Melsungen Aktiengesellschaft, Melsungen, Germany notified us pursuant to section 25 para. 1 WpHG and pursuant to section 25a para. 1 WpHG of the following: 1) B. Braun Melsungen Aktiengesellschaft, Melsungen, Germany notified us pursuant to section 25 para. 1 WpHG of the following: On 31 October 2013, B. Braun Melsungen Aktiengesellschaft exceeded the threshold of 5% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Melsungen Aktiengesellschaft held 6.02% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft arising from 8,322,288 voting rights. From these voting rights a proportion of 3,002% (equals 4,150,000 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 3.02% (equals 4,172,288 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0% (equals 0 voting rights) is held indirectly. The exercise period of the instruments pursuant to section 25 WpHG is October 31, 2013 until November 6, 2013. 2) B. Braun Melsungen Aktiengesellschaft, Melsungen, Germany notified us pursuant to section 25a para. 1 WpHG of the following: On 31 October 2013, B. Braun Melsungen Aktiengesellschaft exceeded the threshold of 5% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft, Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B. Braun Melsungen Aktiengesllschaft held 6.02% of the voting rights in RHÃ?N-KLINIKUM Aktiengesellschaft arising from 8,323,288 voting rights. From these voting rights a proportion of 3,002% (equals 4,150,000 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 3.02% (equals 4,172,288 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0% (equals 0 voting rights) is held indirectly. In addition, a proportion of 0.001% (equals 1,000 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0% (equals 0 voting rights) is held indirectly. The instruments pursuant to section 25a WpHG are sold put options ('Verkaufte Put-Optionen') with expiration date 22 December 2014. Bad Neustadt a.d. Saale, November 4, 2013 The Board of Management ________________________________________________________________ Dr. Kai G. Klinger Head of Investor Relations RHÃ?N-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 04.11.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÃ?N-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------